Autoimmune nodopathy: clinical features
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Autoimmune nodopathy: clinical features. Affected subjects are usually adults, Males are more frequently affected. Fully referenced neurology checklist.
Epidemiology
- Affected subjects are usually adults
- Males are more frequently affected
- Diabetes may be a risk factor
Clinical features
Locked: subscribe to see this section.
Associated features: especially with panNF
Locked: subscribe to see this section.
Associated features: especially with NF155
Locked: subscribe to see this section.
Associated features: with CNTN1 (contactin)
Locked: subscribe to see this section.
Phenotypes
Locked: subscribe to see this section.
Differential diagnosis
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Fehmi J, Vale T, Keddie S, Rinaldi S. Nodal and paranodal antibody-associated neuropathies. Pract Neurol 2021 (Online ahead of print).
- Appeltshauser L, Messinger J, Starz K, et al. Diabetes mellitus is a possible risk factor for nodo-paranodopathy with antiparanodal autoantibodies. Neurol Neuroimmunol Neuroinflamm 2022; 9:e1163.
- Cortese A, Lombardi R, Briani C, et al. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm 2019; 7:e639.
- Martín-Aguilar L, Lleixà C, Pascual-Goñi E, et al. Clinical and laboratory features in anti-NF155 autoimmune nodopathy. Neurol Neuroimmunol Neuroinflamm 2021; 9:e1098.
- Fehmi J, Davies AJ, Walters J, et al. IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality. JNNP 2021; 92:1089-1095.
- And 8 more. Subscribe to see the full list
